Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 19, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biomx Inc.
| 6.11M |
—
|
—
|
∞
| 6.11M |
Mar 15
| |||||||
Biomx Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Adapthealth Corp.
| -350.00K |
$10.90 | -$3,815,703.53 | -2.95% | 11.53M |
Mar 8 - Mar 12
| |||||||
Adapthealth Corp.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Larimar Therapeutics, Inc.
| 4.29M |
$8.74 | $37,499,992.58 | +35.11% | 16.51M |
Feb 16
| |||||||
Fractyl Health, Inc.
| 834.25K |
—
|
—
|
∞
| 834.25K |
Feb 6
| |||||||
Fractyl Health, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Caremax, Inc.
| 12.12K |
—
|
—
|
∞
| 12.12K |
Nov 17
| |||||||
Da32 Life Science Tech Acquisition Corp.
| -1.60M |
—
|
—
| -100.00% |
0
|
Jul 28
| |||||||
Acutus Medical, Inc.
| 16.8K |
—
|
—
| +417.70% | 20.82K |
Jun 16 - Jun 15
| |||||||
Nuvalent, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Caremax, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Larimar Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 9
| |||||||
Oncorus, Inc.
| -336.24K |
$0.26 | -$88,253.72 | -11.46% | 2.6M |
Dec 28 - Dec 30
| |||||||
Oncorus, Inc.
| -73.38K |
$0.27 | -$19,896.62 | -2.44% | 2.93M |
Dec 22 - Dec 27
| |||||||
Oncorus, Inc.
| -128.26K |
$0.29 | -$37,627.62 | -4.09% | 3.01M |
Dec 19 - Dec 21
| |||||||
Oncorus, Inc.
| -13.79K |
$0.39 | -$5,332.48 | -0.44% | 3.14M |
Dec 13 - Dec 15
| |||||||
Caremax, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 17
| |||||||
Frazier Lifesciences Acquisition Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Ars Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Nuvalent, Inc.
| 650K |
$33.50 | $21,775,000.00 |
∞
| 650K |
Nov 3
| |||||||
Larimar Therapeutics, Inc.
| 11.11M |
$3.15 | $34,999,990.20 | +190.58% | 16.94M |
Sep 16
| |||||||
Acutus Medical, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 30
| |||||||
Nuvalent, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 16
| |||||||
Mirum Pharmaceuticals, Inc.
| -38.48K |
$25.01 | -$962,255.52 | -1.17% | 3.24M |
Jun 6
| |||||||
Larimar Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 10
| |||||||
Pepgen Inc.
| 953.63K |
$12.00 |
—
|
∞
| 953.63K |
May 10
| |||||||
Pepgen Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Oncology Institute, Inc.
| 85.15K |
—
|
—
|
∞
| 85.15K |
Nov 12
| |||||||
Xilio Therapeutics, Inc.
| 2.29M |
$16.00 |
—
|
∞
| 2.29M |
Oct 26
| |||||||
Xilio Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Acutus Medical, Inc.
| 1.8K |
—
|
—
| +81.01% | 4.02K |
Jun 17
| |||||||
Da32 Life Science Tech Acquisition Corp.
|
0
|
—
|
—
|
—
|
0
|
Aug 5
| |||||||
Nuvalent, Inc.
| 18.78M |
—
|
—
| +3,369.86% | 19.34M |
Aug 2
| |||||||
Da32 Life Science Tech Acquisition Corp.
| 2.25M |
$10.00 | $22,500,000.00 | +140.63% | 3.85M |
Jul 30
| |||||||
Nuvalent, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 28
| |||||||
Nuvalent, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Da32 Life Science Tech Acquisition Corp.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Acutus Medical, Inc.
| 1.07M |
$14.00 | $14,999,992.00 | +24.68% | 5.41M |
Jul 19
| |||||||
Mirum Pharmaceuticals, Inc.
| -99.33K |
$15.81 | -$1,570,328.25 | -100.00% |
0
|
Jul 9
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.